Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore

By: |
February 01, 2016 5:02 PM

Net sales of the company rose to Rs 465.71 crore for the December quarter Ajanta Pharma has reported a 19.60 per cent increase in consolidated net profit at Rs 111.3 crore for the quarter ended December 31, 2015. The company had posted a net profit of Rs 93.06 crore for the same period of the […]

Net sales of the company rose to Rs 465.71 crore for the December quarter

Ajanta Pharma has reported a 19.60 per cent increase in consolidated net profit at Rs 111.3 crore for the quarter ended December 31, 2015.

The company had posted a net profit of Rs 93.06 crore for the same period of the previous fiscal.

Net sales of the company rose to Rs 465.71 crore for the December quarter, up 15.97 per cent from Rs 401.56 crore in the year-ago period, Ajanta Pharma said in a BSE filing.

“We have established strong sales and marketing network in select international markets which continue to perform well and generate demand for our branded generics.

“However, the currency devaluation and scarcity of forex availability in few emerging markets limited us to achieve our full potential,” said Rajesh Agrawal, Joint Managing Director, Ajanta Pharma.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.